Skip to main content
PMC home page
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 1988 Sep;47(9):733–739. doi: 10.1136/ard.47.9.733

Polymyalgia rheumatica and temporal arteritis: a retrospective analysis of prognostic features and different corticosteroid regimens (11 year survey of 210 patients).

G Delecoeuillerie 1, P Joly 1, A Cohen de Lara 1, J B Paolaggi 1
PMCID: PMC1003589  PMID: 3178314

Abstract

The treatment of polymyalgia rheumatica (PMR) and temporal arteritis (TA) is still controversial. To assess the influence on the course of these diseases of the clinical symptoms at initial presentation and of the starting dosage of corticosteroid (CS) treatment the data for 210 patients, who were diagnosed as having PMR or TA from 1976 to 1986 and were followed up closely, were reviewed. One hundred and thirty two patients were diagnosed as having 'clinically pure' PMR; prednisone starting doses of over 15 mg daily provided more CS related adverse effects without any advantage. The mean duration of treatment was 25.7 months. Nine patients later developed symptoms of TA, and there were no predictive features for this. None experienced visual or neurological complications. Seventy eight patients were diagnosed as having clinical TA. Twenty five patients treated with low starting doses of prednisone, ranging from 10 to 20 mg/d (mean 16.2 mg/d), developed less CS related adverse effects and did not have more visual or neurological complications than 53 patients treated with higher doses. The mean duration of treatment was 30.9 months. Fifteen patients experienced visual or neurological complications and men (10/30) developed these complications more frequently than women (5/48) (p less than 0.02). These results suggest that (a) clinically pure PMR is a benign disease requiring low doses of CS treatment; (b) low doses of CS seem an adequate treatment for most cases of TA; (c) a worse prognosis seems attached to the male sex in TA.

Full text

PDF
733

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ayoub W. T., Franklin C. M., Torretti D. Polymyalgia rheumatica. Duration of therapy and long-term outcome. Am J Med. 1985 Sep;79(3):309–315. doi: 10.1016/0002-9343(85)90309-2. [DOI] [PubMed] [Google Scholar]
  2. Behn A. R., Perera T., Myles A. B. Polymyalgia rheumatica and corticosteroids: how much for how long? Ann Rheum Dis. 1983 Aug;42(4):374–378. doi: 10.1136/ard.42.4.374. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bengtsson B. A., Malmvall B. E. Prognosis of giant cell arteritis including temporal arteritis and polymyalgia rheumatica. A follow-up study on ninety patients treated with corticosteroids. Acta Med Scand. 1981;209(5):337–345. doi: 10.1111/j.0954-6820.1981.tb11604.x. [DOI] [PubMed] [Google Scholar]
  4. Chuang T. Y., Hunder G. G., Ilstrup D. M., Kurland L. T. Polymyalgia rheumatica: a 10-year epidemiologic and clinical study. Ann Intern Med. 1982 Nov;97(5):672–680. doi: 10.7326/0003-4819-97-5-672. [DOI] [PubMed] [Google Scholar]
  5. David-Chaussé J., Dehais J., Leman A. Résultats d'une enquête régionale sur le traitement de la pseudopolyarthrite rhizomélique et de l'artérite temporale. A propos de 242 observations traitées selon diverses modalités par les antipaludéens de synthèse, les corticoïdes et les anti-inflammatoires non stéroïdiens. Rev Rhum Mal Osteoartic. 1983 Jul-Sep;50(8-9):563–571. [PubMed] [Google Scholar]
  6. Fauchald P., Rygvold O., Oystese B. Temporal arteritis and polymyalgia rheumatica. Clinical and biopsy findings. Ann Intern Med. 1972 Dec;77(6):845–852. doi: 10.7326/0003-4819-77-6-845. [DOI] [PubMed] [Google Scholar]
  7. Godeau P., Aubert L., Guillevin L., Tard P., Maaouni A., Wechsler B., Bletry O., Herreman G. Aspect clinique, évolution et pronostic de la maladie de Horton. Etude rétrospective de 47 observations. Ann Med Interne (Paris) 1982;133(6):393–400. [PubMed] [Google Scholar]
  8. Goodman B. W., Jr Temporal arteritis. Am J Med. 1979 Nov;67(5):839–852. doi: 10.1016/0002-9343(79)90744-7. [DOI] [PubMed] [Google Scholar]
  9. HOLLENHORST R. W., BROWN J. R., WAGENER H. P., SHICK R. M. Neurologic aspects of temporal arteritis. Neurology. 1960 May;10:490–498. doi: 10.1212/wnl.10.5.490. [DOI] [PubMed] [Google Scholar]
  10. Hamrin B. Polymyalgia arteritica. Acta Med Scand Suppl. 1972;533:1–131. [PubMed] [Google Scholar]
  11. Huston K. A., Hunder G. G., Lie J. T., Kennedy R. H., Elveback L. R. Temporal arteritis: a 25-year epidemiologic, clinical, and pathologic study. Ann Intern Med. 1978 Feb;88(2):162–167. doi: 10.7326/0003-4819-88-2-162. [DOI] [PubMed] [Google Scholar]
  12. Myles A. B. Polymyalgia rheumatica and giant cell arteritis: a seven-year survey. Rheumatol Rehabil. 1975 Nov;14(4):231–235. doi: 10.1093/rheumatology/14.4.231. [DOI] [PubMed] [Google Scholar]
  13. Paolaggi J. B., Chaouat D., Barres D., Hoffman H., Auquier L. Etude des variations comparées de la vitesse de sédimentation, de l'haptoglobine et de l'orosomucoïde au cours de l'évolution des pseudopolyarthrites rhizoméliques et artérites temporales. Sem Hop. 1983 Feb 24;59(8):523–528. [PubMed] [Google Scholar]
  14. Rosenfeld S. I., Kosmorsky G. S., Klingele T. G., Burde R. M., Cohn E. M. Treatment of temporal arteritis with ocular involvement. Am J Med. 1986 Jan;80(1):143–145. doi: 10.1016/0002-9343(86)90066-5. [DOI] [PubMed] [Google Scholar]
  15. Sorensen S., Lorenzen I. Giant-cell arteritis, temporal arteritis and polymyalgia rheumatica. A retrospective study of 63 patients. Acta Med Scand. 1977;201(3):207–213. doi: 10.1111/j.0954-6820.1977.tb15683.x. [DOI] [PubMed] [Google Scholar]
  16. Spiera H., Davison S. Long-term follow-up of polymyalgia rheumatica. Mt Sinai J Med. 1978 Mar-Apr;45(2):225–229. [PubMed] [Google Scholar]
  17. Spiera H., Davison S. Treatment of polymyalgia rheumatica. Arthritis Rheum. 1982 Jan;25(1):120–120. doi: 10.1002/art.1780250124. [DOI] [PubMed] [Google Scholar]
  18. Vilaseca J., González A., Cid M. C., Lopez-Vivancos J., Ortega A. Clinical usefulness of temporal artery biopsy. Ann Rheum Dis. 1987 Apr;46(4):282–285. doi: 10.1136/ard.46.4.282. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES